All Articles Tagged With: "Sanofi-Aventis"
Articles
Prilosec Side Effects Interfere with Effectiveness of Plavix: FDA Warns
The FDA has issued a public health advisory warning that side effects of Prilosec, a stomach acid reducer, may interfere with the effectiveness of Plavix, an anti-blood clotting medication, increasing the risk of a heart attack, death or other injuries for patients.
Uroxatral Risks Not Adequately Disclosed in Advertisements: FDA Warns
The FDA issued a warning letter to drug maker Sanofi-Aventis over the use of certain promotional materials for its prostate drug Uroxatral, which were described as “misleading” for failing to properly indicate the risk of potential side effects.
Plavix Ineffectiveness Predicted By Gene Variant Found in One of Three People
Researchers from the University of Maryland have identified a gene variant found in about one-third of the population, which may be a factor in causing the blood thinner Plavix not to work, increasing the risk that users may suffer a subsequent heart attack, stroke or other heart problem.
Lantus Cancer Risk Being Reviewed by FDA
The FDA is reviewing new information about potential Lantus cancer side effects after several observational studies were published that suggest the artificial insulin may be associated with an increased incidence of cancer. However, the agency has expressed doubts about whether a connection between the use of Lantus and cancer truly exists.
Lantus Insulin Side Effects Linked to Risk of Cancer: Study
New research suggests that side effects of Lantus, an artificial form of insulin manufactured by Sanofi-Aventis for diabetes, may increase the risk of developing cancer.
Plavix Lawsuits Moving Forward Towards Trial
After months of delay awaiting a Supreme Court decision about whether FDA approval preempts cases against drug makers for failing to warn about dangerous side effects, a U.S. District Judge in New Jersey has reinstated dozens of Plavix lawsuits pending against Bristol-Myers and Sanofi Aventis, allowing the claims to move closer to trial.
